Skip to main navigation
  • LogicBio Therapeutics, Inc.

Investors

  • About
  • GeneRide
  • Pipeline
  • Patients & Families
    • Yusuf's Story
    • Khadija's Story
    • Melissa's Story
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Analyst Coverage
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • IR Search
  • Careers
  • Contact

Investors Menu

  • Overview
  • Press Releases
  • Events and Presentations
    • Event Calendar
    • Presentations
  • Stock Information
    • Stock Chart & Quote
    • Historic Price Lookup
    • Investment Calculator
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • SEC Filings
  • Analyst Coverage
  • Investor FAQs
  • Email Alerts
  • Contact IR
  • IR Search

SEC Filing Details

SEC Filing Details

Document Details

Form
3
Filing Date
Oct 18, 2018
Document Date
Oct 18, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
LogicBio Therapeutics, Inc.
Issuer
LogicBio Therapeutics, Inc.
Filer
Falb Dean

Filing Formats

View HTML
Download PDF
Download DOC
© 2021 LogicBio Therapeutics, Inc.
  • Privacy Policy
  • Contact